All Sauce from Weekly Sauce:

If more proof of the safety of vaccines is needed, a new study delivers fresh evidence that they carry few harms for children, adults and pregnant women. “This in-depth analysis found no evidence of increased risk of serious adverse events following vaccines, apart from a few — previously known — associations,” said Susanne Hempel, director…  read on >  read on >

Researchers who pinpointed 178 gene variants linked to major depression say their findings could improve diagnosis and treatment of a disorder that affects 1 in 5 people. The study draws on a huge database, analyzing the genetic and health records of 1.2 million people from three databanks in the United States, the U.K. and Finland,…  read on >  read on >

In a finding that demonstrates the power of a mother’s touch, new research shows that immediate and continuous skin-to-skin contact with mom reduces the risk of death for low-weight newborns in poorer nations. “The idea of giving skin-to-skin contact immediately after delivery to very small, unstable babies has encountered quite strong resistance, but about 75%…  read on >  read on >

Adults with obsessive-compulsive disorder, a common mental health condition known as OCD, may have more than triple the risk of having a stroke, according to a new report from Taiwanese researchers. As to why, the study authors aren’t sure. The investigators speculate that other mental health problems suffered by OCD patients — “comorbidities” such as…  read on >  read on >

Angry outbursts at the office, threats made in everyday interactions: New research using data from hundreds of studies suggests folks who act out in this way often have narcissistic traits. They don’t even have to rate high in narcissism to be prone to aggressive behavior, the research team found. “Those who are high in narcissism…  read on >  read on >

An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But they also stressed that the findings are based on a small “phase 1”…  read on >  read on >

A third antibody treatment designed to keep high-risk COVID-19 patients from winding up in the hospital was approved for emergency use by the U.S. Food and Drug Administration on Wednesday. Importantly, in lab tests the newly authorized drug, dubbed sotrovimab, neutralized the highly infectious virus variant that is crippling India, as well as variants first…  read on >  read on >